Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/29/2020
Merck, Bristol Myers, AstraZeneca and Roche Lose Bid to Expand PD-1/L1...
12/28/2020
NHSA and MOHRSS Issue the 2020 National Reimbursement Drug List
12/28/2020
Chinese Hypertension Prevalence Up 27.5% in the Past Five Years
12/28/2020
China Ups Drug Regulation, Biosecurity and IPR Protection in Amendment...
12/28/2020
Fourth National Level Volume-base Procurement Tender Initiated
12/28/2020
InnoCare's Orelabrutinib Approved in China for rrCLL/SLL/rrMCL
12/25/2020
Recent Executive Moves
12/25/2020
NHSA Issues Notice on Accelerating and Facilitating Drug Price and Ten...
12/25/2020
CDE Issues the Technical Guidelines for Pharmaceutical Research of Gen...
12/25/2020
NHC Issues the Guidance Opinions for Strengthening Public Hospital Ope...
12/24/2020
Obesity Continues to Surge in China Due to Unhealthy Lifestyles
12/24/2020
NMPA Issues the List of Reference Formulations for GQCE Studies (33th ...
12/24/2020
NMPA Issues the List of Reference Formulations for GQCE Studies (34th ...
12/24/2020
NHC Issues the Measures for Clinical Application of Anticancer Drugs
12/24/2020
Chinese Biopharma Cos Staging A Gold Rush at HKSE and SSE STAR Board
12/23/2020
Bayer Sells Biologics Facility in Germany to WuXi Biologics
12/23/2020
NMPA Solicits Comments on the Draft Provisions for Registration of Lic...
12/23/2020
ByteDance Joins Other Chinese IT Giants for Opportunities in AI Drug ...
12/23/2020
Innovent Granted New Indication Approvals for SULINNO (Adalimumab Inj...
12/23/2020
China to Lower Import Tariffs on 883 Products with Zero Duty for 43 An...
12/23/2020
Sinovac Covid Vaccine Over 50% Effective with Inadequate Transparency
12/23/2020
PharmaDJ: PSR Filing System Landed
12/22/2020
NMPA Issues the Measures for Batch Release of Biological Products
12/22/2020
NMPA Sets Up the Yangtze River Delta Sub-centers for Drug and Device E...
12/21/2020
NMPA Publicizes the List of Reference Formulations for GQCE Studies (3...
12/21/2020
NMPA Publicizes the List of Reference Formulations for GQCE Studies (3...
12/21/2020
Review and Forecast of Chinese Antiviral Drug Market 2013-2030E
12/21/2020
Astellas Enters Import and Commercialization Pact with Baheal for AML ...
12/21/2020
CDE Issues the Technical Guidelines for Clinical Research of Drugs for...
12/21/2020
Takeda to Divest Select Assets in China to Hasten Biopharma for $322M
Page:
221
/
789
Total number of articles:
23668
:
[First]
[<<]
[219]
[220]
[221]
[222]
[223]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit